This is a return to form for Dupixent, which was one of the top Rx and OTC pharma brands in 2023 but was outperformed by the likes of Vicks and Rinvoq in early 2024.
Vicks had an estimated national TV ad spend of $15.1 million and received most of its impressions SOV from CBS, in particular its college football broadcasts.
Skyrizi goes sky-high in October among Rx, OTC pharma brands
Overall, Skyrizi had 3.1 billion impressions and an estimated national TV ad spend of $45.6 million, which was the highest among the top 10 pharma brands.
Dupixent returns as top Rx, OTC brand for September
This is a return to the top of the leaderboard for Skyrizi, which is always in the running for the Rx and OTC pharma brand crown but has only been ranked first on a monthly basis once this year.
AI Deciphered: Discovering the Potential for Marketers and Communicators